IGM Biosciences Inc.

NASDAQ: IGMS · Real-Time Price · USD
1.27
0.00 (0.00%)
At close: Aug 13, 2025, 3:59 PM
1.28
0.79%
After-hours: Aug 13, 2025, 06:49 PM EDT

IGM Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
26.5M 112.52M 121.23M 133.33M
Short-Term Investments
157.29M 225.16M 305.93M 96.21M
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
1.06M 1.81M 2M 1.04M
Receivables
800K n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
9.03M 1.39M 11.26M 701K
Total Current Assets
193.62M 347.6M 438.42M 240.75M
Property-Plant & Equipment
71.03M 74M 73.08M 56.34M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
72.09M 75.81M 75.08M 57.38M
Total Assets
265.71M 423.41M 513.5M 298.13M
Account Payables
983K 1.33M 2.51M 5.58M
Deferred Revenue
2.65M 3.78M 148.93M n/a
Short-Term Debt
n/a n/a 5.82M 3.32M
Other Current Liabilities
10.2M 13.53M 16.89M 8.81M
Total Current Liabilities
37.64M 42.48M 44.69M 27.78M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
366K n/a n/a n/a
Total Long-Term Liabilities
179.9M 177.7M 181.55M 25.44M
Total Liabilities
217.54M 220.18M 226.24M 53.22M
Total Debt
45.19M 40.51M 41.17M 28.76M
Common Stock
342K 586K 431K 325K
Retained Earnings
-1.02B -821.24M -574.83M -353.72M
Comprehensive Income
159K 151K -701K -66K
Shareholders Equity
48.17M 203.23M -574.83M -353.72M
Total Investments
157.29M 225.16M 305.93M 96.21M